9 Role of thyroid transcription factor-1 in pulmonary adenocarcinoma

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas

Volumn 1, Issue , 2002, Pages 169-179

  Yatabe, Yasushi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649311804     PISSN: 18745784     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5784(04)80028-X     Document Type: Chapter

References (59)

1. Agoff S.N., Lamps L.W., Philip A.T., Amin M.B., Schmidt R.A., True L.D., and Folpe A.L. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod. Pathol. 13 (2000) 238-242
2. Akashi K., He X., Chen J., Iwasaki H., Niu C., Steenhard B., Zhang J., Haug J., and Li L. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101 (2003) 383-389
3. Amin M.B., Tamboli P., Merchant S.H., Ordonez N.G., Ro J., Ayala A.G., and Ro J.Y. Micropapillary component in lung adenocarcinoma: A distinctive histologic feature with possible prognostic significance. Am. J. Surg. Pathol. 26 (2002) 358-364
4. Bejarano P.A., Nikiforov Y.E., Swenson E.S., and Biddinger P.W. Tyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem. Mol Morphol. 8 (2000) 189-194
5. Berman J., and O'Leary T.J. Gastrointestinal stromal tumor workshop. Hum. Pathol. 32 (2001) 578-582
6. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., and Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98 (2001) 13790-13795
7. Bruno M.D., Bohinski R.J., Huelsman K.M., Whitsett J.A., and Korfhagen T.R. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription f. J. Biol. Chem. 270 (1995) 6531-6536
8. Carnaghi C., Rimassa L., Garassino I., and Santoro A. Clinical significance of neuroendocrine phenotype in nonsmall cell lung cancer. Ann. Oncol. 12 Suppl. 12 (2001) S119-S123
9. Corti M., and Snyder C.A. Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol. Sci. 41 (1998) 42-48
10. Demetri G.D. Targeting c-kit mutations in solid tumors: Scientific rationale and novel therapeutic options. Scmin. Oncol. 28 (2001) 19-26
11. Di Loreto C., Di Lauro V., Puglisi F., Damante G., Fabbro D., and Beltrami C.A. Immunocytoehemical expression of tissue-specific transcription factor-1 in lung carcinoma. J. Clin. Pathol. 50 (1997) 30-32
12. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-rcgulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
13. Endl E., Kausch I., Baack M., Knippers R., Gerdes J., and Scholzen T. The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells. J. Pathol. 195 (2001) 457-462
14. Fabbro D., Di Loreto C., Stamerra O., Beltrami C.A., Lonigro R., and Damante G. TTF-1 gene expression in human lung tumours. Eur. J. Cancer 32A (1996) 512-517
15. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., and Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 98 (2001) 13784-13789
16. Graziano S.L., Tatum A.H., Newman N.B., Oler A., Kohman L.J., Veit L.J., Gamble G.P., Coleman M.J., Barmada S., and O'Leary S. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II nonsmall cell lung cancer. Cancer Res. 54 (1994) 2908-2913
17. Heldin N.E., and Westermark B. The molecular biology of the human anaplastic thyroid carcinoma cell. Thyroidology 3 (1991) 127-131
18. Hibi K., Takahashi T., Sekido Y., Ueda R., Hida T., Ariyoshi Y., and Takagi H. Coexpression of the stem cell factor and the c-kit genes in small cell lung cancer. Oncogene 6 (1991) 2291-2296
19. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., Silberman S., Capdeville R., Dimitrijevic S., Druker B., and Demetri G.D. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 344 (2001) 1052-1056
20. Katoh R., Kawaoi A., Miyagi E., Li X., Suzuki K., Nakamura Y., and Kakudo K. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hy. Mod. Pathol. 13 (2000) 570-576
21. Kaufmann O., and Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant prote. Histopathology 36 (2000) 8-16
22. Kelly S.E., Bachurski C.J., Burhans M.S., and Glasser S.W. Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1. J. Biol. Chem. 271 (1996) 6881-6888
23. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., and Gonzalez F.J. The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dew 10 (1996) 60-69
24. Kobayashi T., Tsuda H., Noguchi M., Hirohashi S., Shimosato Y., Goya T., and Hayata Y. Association of point mutation in c-Ki-Ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes. Cancer 66 (1990) 289-294
25. Korfhagen T.R., and Whitsett J.A. Transcriptional control in the developing lung: The Parker B. Francis lectureship. Chest 111 (1997) 83S-88S
26. Kozaki K., Koshikawa K., Tatematsu Y., Miyaishi O., Saito H., Hida T., Osada H., and Takahashi T. Multifaceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. Oncogene 20 (2001) 4228-4234
27. Lazzaro D., Price M., de Felice M., and Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113 (1991) 1093-1104
28. Marchetti A., Buttitta F., Pellegrini S., Chella A., Bertacca G., Filardo A., Tognoni V., Ferreli F., Signorini E., Angeletti C.A., and Bevilacqua G. Bronchioloalveolar lung carcinomas: K-Ras mutations are constant events in the mucinous subtype. J. Pathol. 179 (1996) 254-259
29. Mendelson C.R. Role of transcription factors in fetal lung development and surfactant protein gene expression. Annu. Rev. Physiol. 62 (2000) 875-915
30. Minoo P., Su G., Drum H., Bringas P., and Kimura S. Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dew Biol. 209 (1999) 60-71
31. Niki T., Kohno T., Iba S., Moriya Y., Takahashi Y., Saito M., Maeshima A., Yamada T., Matsuno Y., Fukayama M., Yokota J., and Hirohashi S. Frequent colocalization of COX2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol. 160 (2002) 1129-1141
32. Nishio M., Koshikawa T., Yatabe Y., Kuroishi T., Suyama M., Nagatake M., Sugiura T., Ariyoshi Y., Mitsudomi T., and Takahashi T. Prognostic significance of cyclin DI and retinoblastoma expression in combination with p53 abnormalities in preimary, resected nonsmall cell lung cancers. Clin. Cancer Res. 3 (1997) 1051-1058
33. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., Kondo H., and Shimosato Y. Small adenocarcinoma of the lung: Histologic characteristics and prognosis. Cancer 75 (1995) 2844-2852
34. Oliveira A.M., Tazelaar H.D., Myers J.L., Erickson L.A., and Lloyd R.V. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am. J. Surg. Pathol. 25 (2001) 815-819
35. Ordonez N.G. Thyroid transcription factor-1 is a marker of lung and thryroid carcinomas. Adv. Anat. Pathol. 7 (2000) 123-127
36. Ordonez N.G. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am. J. Surg. Pathol. 24 (2000) 1217-1223
37. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., and Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
38. Pelosi G., Fraggetta F., Pasini F., Maisonneuve P., Sonzogni A., Iannucci A., Terzi A., Bresaola E., Valduga F., Lupo C., and Viale G. Immunoreactivity for thyroid transcription factor-1 in stage I nonsmall cell carcinomas of the lung. Am. J. Surg. Pathol. 25 (2001) 363-372
39. Puglisi F., Barbone F., Damante G., Bruckbauer M., Di Lauro V., Beltrami C.A., and Di Loreto C. Prognostic value of thyroid transcription factor-1 in primary, resected, nonsmall cell lung carcinoma. Mod. Pathol. 12 (1999) 318-324
40. Ramirez M.I., Rishi A.K., Cao Y.X., and Williams M.C. TGT3, thyroid transcription factor I, and Spl elements regulate transcriptional activity of the 1.3-kilobase pair promoter of T1 alpha, a lung alveolar type I. J. Biol. Chem. 272 (1997) 26285-26294
41. Rivard N., L Allemain G., Bartek J., and Pouyssegur J. Abrogation of p27Kipl by cDNA antisense suppresses quiescence (GO state) in fibroblasts. J. Biol. Chem. 277 (1996) 18337-18341
42. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., and Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55 (1995) 3785-3789
43. Sekido Y., Obata Y., Ueda R., Hida T., Suyama M., Shimokata K., Ariyoshi Y., and Takahashi T. Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. Cancer Res. 51 (1991) 2416-2419
44. Shamblott M.J., Axelman J., Littlefield J.W., Blumenthal P.D., Huggins G.R., Cui Y., Cheng L., and Gearhart J.D. Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. USA 98 (2001) 113-118
45. Shimosato Y. Pulmonary neoplasms. In: Sternberg S.S. (Ed). Diagnostic Surgical Pathology (1989), Raven Press, New York 785-827
46. Stahlman M.T., Gray M.E., and Whitsett J.A. Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung. J. Histochem. Cytochem. 44 (1996) 673-678
47. Sturm N., Rossi G., Lantuejoul S., Papotti M., Franchon S., Claraz C., Brichon P.Y., Brambilla C., and Brambilla E. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum. Pathol. 33 (2002) 175-182
48. Sugita M., Geraci M., Gao B., Powell R.L., Hirsch F.R., Johnson G., Lapadat R., Gabrielson E., Bremnes R., Bunn P.A., and Franklin W.A. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma. Cancer Res. 62 (2002) 3971-3979
49. Toonen R.F., Gowan S., and Bingle C.D. The lung enriched transcription factor TTF-1 and the ubiquitously expressed proteins Spl and Sp3 interact with elements located in the minimal promoter of the. Biochem. J. 316 (1996) 467-473
50. Travis W.D., Colby T.V., Sobin S.H., Corrin B., Shimosata Y., and Brambilla E. Histological Typing of Lung and Pleural Tumors. 3rd ed. (1999), Springer-Verlag, New York
51. Vane J. Towards a better aspirin. Nature 367 (1994) 215-216
52. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T.K., Turner D., Rupp R., Hollenberg S., et al. The myoD gene family: Nodal point during specification of the muscle cell lineage. Science 251 (1991) 761-766
53. Williams C.S., Smalley W., and DuBois R.N. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest. 100 (1997) 1325-1329
54. Yan C., Sever Z., and Whitsett J.A. Upstream enhancer activity in the human surfactant protein B gene is mediated by thyroid transcription factor 1. J. Biol. Chem. 270 (1995) 24852-24857
55. Yatabe Y., Hida T., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., Ogawa M., Mitsudomi T., Sugiura T., and Takahashi T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 58 (1998) 3761-3764
56. KIP1 in human lung cancers: Differential changes in small cell and nonsmall cell carcinomas. Cancer Res. 58 (1998) 1042-1047
57. Yatabe Y., Mitsudomi T., and Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am. J. Surg. Pathol. 26 (2002) 767-773
58. Zhang X., Wharton W., Donovan M., Coppola D., Croxton R., Cress W.D., and Pledger W.J. Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kipl). Mol. Biol. Cell 11 (2000) 2117-2130
59. Zhou L., Lim L., Costa R.H., and Whitsett J.A. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J. Histochem. Cytochem. 44 (1996) 1183-1193